{"company":{"slug":"matchpoint-therapeutics","name":"Matchpoint Therapeutics","stage":"series-b+","industry":"bio-health","subcategory":null,"sector":"Biotechnology, Medical, Pharmaceutical","description":"Matchpoint Therapeutics discovers precision small molecule medicines that use covalency to treat immune diseases and other serious illnesses. The company uses its Advanced Covalent Exploration platform, which integrates chemoproteomics, machine learning, and covalent chemistry library evolution. Matchpoint has an emerging pipeline of novel covalent medicines.","crypto":false,"first_seen_at":"2026-10-08T17:14:49.253Z","hq_city":"Cambridge","hq_country":"United States","founded_year":2021,"website":"https://matchpointtx.com/","x_handle":"matchpointtx","followers":134,"logo":"https://recentfunding.com/logo/e/lwCK5SaLo7PSiraFKG2S6cuqtrrMJQxt5uo2VEFEHkeXfTTddil8bwzv8KuCeHp3Bz63BkBMje2SmpvOiKJ3iXIs5-ebF0avp-Ux9deIzZir1PKJLqJPKW1Wug","amount_usd":"150000000.00","announced_at":"2026-10-07T00:00:00.000Z","raise_source_url":"https://www.bioworld.com/articles/734544-new-financing-at-matchpoint-therapeutics-to-advance-lead-program","raise_publisher":"bioworld.com","raise_provider":"press","sources":[],"investors":["Access Biotechnology","Atlas Venture","BB Biotech","BOLD Longevity Growth Fund","Digitalis Ventures","Invus","Nextech Invest","Norwest Venture Partners","Sanofi Ventures","T1D Fund"],"flagged":false,"flagged_at":null,"source_links":{},"x_created_at":"2022-01-20","domain_created_at":"2021-12-01","smart_follows":null,"days_early":null,"new_follows_7d":null,"trending_rank":null,"team_size":null,"team_source_url":null,"headcount":"11-50","acquired_by":null,"categories":["health-bio","education"]},"rounds":[{"stage":"series-b+","kind":null,"amount_usd":"150000000.00","valuation_usd":null,"announced_at":"2026-10-07T00:00:00.000Z","source_url":"https://www.bioworld.com/articles/734544-new-financing-at-matchpoint-therapeutics-to-advance-lead-program","source_publisher":"bioworld.com","source_provider":"press"},{"stage":"series-a","kind":null,"amount_usd":"100000000.00","valuation_usd":null,"announced_at":"2022-10-17T00:00:00.000Z","source_url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxNaWdQUVU3eTEta051VVo3ZFRpQVRoWmRsQVNnb0d6TWZ6d1ROU3M1SUVTRldFR3l3aGxYem1vRGxCUjV3SkU0aGY5NU5WU1ZlcWh5UzlEZmpWbHh5T3VWZkZjQ0lQNS11OUdDVUxGdmlzd2tVaDBocWlyckxsUXFqTUotU2JkYi1tcnR3UE5TUQ?oc=5","source_publisher":"citybiz","source_provider":"google-news"}],"founders":[{"name":"Edward Chouchani","x_handle":"echouchani","linkedin_url":"https://www.linkedin.com/in/edward-chouchani-a7137320","avatar":"https://recentfunding.com/logo/e/jyy1fRoSdJv0oaRW16NRZtlABomBBkExv7RLmVKwHPYt2HQ1aMx6euipp62BhUZ2W3EgBabgxh8RnMnZcLeNQTZAD8O3_--__UuuutDT8gVWmie9B1mOEoFPaQ","role":"Founder","source_url":null,"other_companies":[]},{"name":"Jianwei Che","x_handle":null,"linkedin_url":"https://www.linkedin.com/in/jianwei-che-a736025","avatar":"https://recentfunding.com/logo/e/ZkD2D57k91xrQTfiCqq2wg02dJ55MOL9bYQULj_myzV03DZj0BDt67e-LsTD6UdmkLXzVjYJ-46gEoXGyZ3pzHUpKh4MPxm_qsEXD01obcClDagYF88c6zA55Q","role":"Founder","source_url":null,"other_companies":[]},{"name":"Nathanael Gray","x_handle":null,"linkedin_url":"https://www.linkedin.com/in/nathanael-gray-97b019a","avatar":"https://recentfunding.com/logo/e/0WG5oxOw-WS6HlRk6TDnYrpiFZQ8EETaKMZCF4aTnAvy7Xu_LmwzwELCtDPvFADQCoAnEhS5zq3OiRj_z6AyAbmqTmYEYphSN-TV5nmTr-tv1xUtGw-RQZn2SQ","role":"Founder","source_url":null,"other_companies":[]},{"name":"Tinghu Zhang","x_handle":null,"linkedin_url":"https://www.linkedin.com/in/tinghuzhang","avatar":"https://recentfunding.com/logo/e/QzhusD8fnRB_v-FEhxVGpwd--E-LDR1-LTbDvcDyJyLFNzC6QiMeXkGgyOLTORpi0x0c5b1_RicEFAe6DOxWhwXtAK_S2a1-Z1cid1ouKSFcHi3RiRNFwCQ9cg","role":"Founder","source_url":null,"other_companies":[]},{"name":"G. Andre Turenne","x_handle":null,"linkedin_url":null,"avatar":"https://recentfunding.com/logo/e/0SVq1InS7ulBEWsAM_Tf--az7UoLe83hboS7DQs3gsvvQJebLZ5wqySMMzH87CL3pVbM1oraErPG7ZWYI7Ads_0uqqJiIGBn3TobaJIhdiK5bNYf4ywxctYX2NYqfhPbKZHn9MQ9yGdC6XMzW1H-A2OpRYvpGkY","role":"President and CEO","source_url":null,"other_companies":[]},{"name":"Jared Cumming","x_handle":null,"linkedin_url":null,"avatar":"https://recentfunding.com/logo/e/4rDJD50_bC8yD7-KTpVS8FINg80QbdMLPhVV2LAvffWr2f7w2zvK4jQHhg04OAFwfvN-9baIyl8pUhjHXkKqSRzNekw7coFTIlqzE81bADYEQ-8GeijdWB-piw","role":"Chief Scientific Officer","source_url":null,"other_companies":[]}],"meta":{"notice":"No API key: 10000 requests a day per client, then a 429. Get a free key with just an email: POST https://recentfunding.com/api/keys/new with the JSON body {\"email\": \"you@example.com\"} (or use the form at https://recentfunding.com/api-key/). The answer's \"key\" starts with rf_; send it on every request as the header \"Authorization: Bearer rf_...\" (X-API-Key: rf_... or ?api_key=rf_... also work).","get_key":"https://recentfunding.com/api-key/","create_key":{"method":"POST","url":"https://recentfunding.com/api/keys/new","body":{"email":"you@example.com"}},"send_key":"Authorization: Bearer rf_...","daily_limit":10000,"remaining_today":9320}}